Thyme Care, a Nashville, TN-based value-based cancer care partner, raised $60 million in Series B funding, per Fortune’s Term Sheet. Town Hall Ventures and Foresite Capital led the round and were joined by Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital, and Frist Cressey Ventures.
Related Posts
MindMaze Scores $125M for Rehab Treatment
AlbaCore Capital Group made the investment.
October 11, 2021
Triton Pacific Capital Partners Invests in Integrated Pain Associates
Florac and Star Mountain Capital participated in the investment. Terms of the transaction were not disclosed. DLA Piper advised Triton Pacific.
January 10, 2023